O33 Longitudinal Assessment of Biomarkers in NOBILITY, a Randomized, Phase II Clinical Trial of Obinutuzumab for Treatment of Proliferative Lupus Nephritis
Lupus Science and Medicine(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Lupus Science and Medicine(2024)